Skip to content

Common Stock at other companies

IAR
Integra LifeSciencesIART
240M0.0%
MiMedx Group logo
MiMedx GroupMDXG
250M0.0%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$13K0.0%
Solventum logo
SolventumSOLV
750M0.0%
The Beauty Health Company logo
The Beauty Health CompanySKIN
320M0.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
90M0.0%

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s common stock?
SANUWAVE Health, Inc. (SNWV) reported common stock of 2.5B in Q1 2026.
How has SANUWAVE Health, Inc.'s common stock changed year-over-year?
SANUWAVE Health, Inc.'s common stock decreased by 0.0% year-over-year, from 2.5B to 2.5B.
What is the long-term trend for SANUWAVE Health, Inc.'s common stock?
Over 4 years (2021 to 2025), SANUWAVE Health, Inc.'s common stock has grown at a 748.6% compound annual growth rate (CAGR), from 482K to 2.5B.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).